Literature DB >> 19516266

Stromal expression of MMP-13 is required for melanoma invasion and metastasis.

Paola Zigrino1, Isolde Kuhn, Tobias Bäuerle, Jan Zamek, Jay W Fox, Susanne Neumann, Alexander Licht, Marina Schorpp-Kistner, Peter Angel, Cornelia Mauch.   

Abstract

Tumor invasion and metastasis of malignant melanoma have been shown to require proteolytic degradation of the extracellular environment achieved primarily by enzymes of the matrix metalloproteinases (MMP) family. We have earlier shown that increased enzyme activity is localized at the border of tumor cells and the adjacent peritumoral connective tissue, emphasizing the importance of tumor-stroma interactions in the regulation of MMP activity. To confirm the role of stroma-derived MMP-13 in the invasion process, we investigated the invasiveness of melanoma cells upon intradermal injection in mice with complete inactivation of MMP-13. Tumor growth was significantly impaired in mmp-13(-/-) mice and most significant at early time points as compared with wild-type littermates. Moreover, metastasis to various organs was reduced to 17.6 vs 30% in lungs, 2.9 vs 30% in the liver. Strikingly, ablation of MMP-13 completely abrogated formation of metastasis in the heart (0 vs 40%). Notably, decreased tumor growth in mmp-13(-/-) mice was associated with reduced blood vessel density. In addition, decreased blood vessel permeability in the tumors was measured by magnetic resonance imaging of tumor-bearing animals. These data suggest an important role of MMP-13 in tumor growth and an unexpected role in organ-specific metastasis of melanoma cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19516266     DOI: 10.1038/jid.2009.130

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  40 in total

1.  Variability in melanoma metalloproteinase expression profiling.

Authors:  Orsi Giricz; Janelle L Lauer; Gregg B Fields
Journal:  J Biomol Tech       Date:  2010-12

Review 2.  Cancer models in Caenorhabditis elegans.

Authors:  Natalia V Kirienko; Kumaran Mani; David S Fay
Journal:  Dev Dyn       Date:  2010-05       Impact factor: 3.780

3.  The dual role of TLR3 in metastatic cell line.

Authors:  Tanja Matijevic; Jasminka Pavelic
Journal:  Clin Exp Metastasis       Date:  2011-07-07       Impact factor: 5.150

Review 4.  Proteases in cutaneous malignant melanoma: relevance as biomarker and therapeutic target.

Authors:  Eleonore Fröhlich
Journal:  Cell Mol Life Sci       Date:  2010-08-05       Impact factor: 9.261

5.  Virtual High-Throughput Screening for Matrix Metalloproteinase Inhibitors.

Authors:  Jun Yong Choi; Rita Fuerst
Journal:  Methods Mol Biol       Date:  2017

Review 6.  Progression of cutaneous melanoma: implications for treatment.

Authors:  Stanley P L Leong; Martin C Mihm; George F Murphy; Dave S B Hoon; Mohammed Kashani-Sabet; Sanjiv S Agarwala; Jonathan S Zager; Axel Hauschild; Vernon K Sondak; Valerie Guild; John M Kirkwood
Journal:  Clin Exp Metastasis       Date:  2012-08-15       Impact factor: 5.150

7.  The disintegrin-like and cysteine-rich domains of ADAM-9 mediate interactions between melanoma cells and fibroblasts.

Authors:  Paola Zigrino; Roswitha Nischt; Cornelia Mauch
Journal:  J Biol Chem       Date:  2010-12-06       Impact factor: 5.157

8.  Bone marrow-derived myofibroblasts are the providers of pro-invasive matrix metalloproteinase 13 in primary tumor.

Authors:  Julie Lecomte; Anne Masset; Silvia Blacher; Ludovic Maertens; André Gothot; Marie Delgaudine; Françoise Bruyère; Oriane Carnet; Jenny Paupert; Martin Illemann; Jean-Michel Foidart; Ida K Lund; Gunilla Høyer-Hansen; Agnes Noel
Journal:  Neoplasia       Date:  2012-10       Impact factor: 5.715

9.  MMP13 as a stromal mediator in controlling persistent angiogenesis in skin carcinoma.

Authors:  Wiltrud Lederle; Bettina Hartenstein; Alice Meides; Heike Kunzelmann; Zena Werb; Peter Angel; Margareta M Mueller
Journal:  Carcinogenesis       Date:  2009-11-05       Impact factor: 4.944

10.  Microenvironmental Th9 and Th17 lymphocytes induce metastatic spreading in lung cancer.

Authors:  Ylia Salazar; Xiang Zheng; David Brunn; Hartmann Raifer; Felix Picard; Yajuan Zhang; Hauke Winter; Stefan Guenther; Andreas Weigert; Benno Weigmann; Laure Dumoutier; Jean-Christophe Renauld; Ari Waisman; Anja Schmall; Amanda Tufman; Ludger Fink; Bernhard Brüne; Tobias Bopp; Friedrich Grimminger; Werner Seeger; Soni Savai Pullamsetti; Magdalena Huber; Rajkumar Savai
Journal:  J Clin Invest       Date:  2020-07-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.